Gusterson B - Search Results

1

Duct carcinoma-in-situ: can we predict recurrence after surgery?

Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Price P, et al. Among authors: gusterson b. Lancet. 1989 Sep 16;2(8664):671-2. doi: 10.1016/s0140-6736(89)90908-2. Lancet. 1989. PMID: 2570913 No abstract available.

2

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.

Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Price P, et al. Among authors: gusterson b. Br J Cancer. 1990 Jun;61(6):869-72. doi: 10.1038/bjc.1990.194. Br J Cancer. 1990. PMID: 2164835 Free PMC article.

3

Intratumoral aromatase as a prognostic factor in human breast carcinoma.

Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC. Silva MC, et al. Among authors: gusterson b. Cancer Res. 1989 May 15;49(10):2588-91. Cancer Res. 1989. PMID: 2713843

4

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.

Rahman N, Stone JG, Coleman G, Gusterson B, Seal S, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS. Rahman N, et al. Among authors: gusterson b. Br J Cancer. 2000 Feb;82(3):568-70. doi: 10.1054/bjoc.1999.0965. Br J Cancer. 2000. PMID: 10682667 Free PMC article.

5

Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast.

Stone JG, Coleman G, Gusterson B, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS. Stone JG, et al. Among authors: gusterson b. Cancer Lett. 2001 Jun 26;167(2):171-4. doi: 10.1016/s0304-3835(01)00448-7. Cancer Lett. 2001. PMID: 11369138

6

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

Smith IE, Walsh G, Jones A, Prendiville J, Johnston S, Gusterson B, Ramage F, Robertshaw H, Sacks N, Ebbs S, et al. Smith IE, et al. Among authors: gusterson b. J Clin Oncol. 1995 Feb;13(2):424-9. doi: 10.1200/JCO.1995.13.2.424. J Clin Oncol. 1995. PMID: 7844604 Clinical Trial.

7

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.

Osin P, Crook T, Powles T, Peto J, Gusterson B. Osin P, et al. Among authors: gusterson b. Lancet. 1998 May 16;351(9114):1487. doi: 10.1016/S0140-6736(98)24020-7. Lancet. 1998. PMID: 9605807 No abstract available.

8

Helix pomatia in breast cancer.

Taylor CW, Anbazhagan R, Jayatilake H, Adams A, Gusterson BA, Price K, Gelber RD, Goldhirsch A. Taylor CW, et al. Among authors: gusterson ba. Lancet. 1991 Aug 31;338(8766):580-1. doi: 10.1016/0140-6736(91)91154-m. Lancet. 1991. PMID: 1678842 No abstract available.

9

Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.

Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM. Cote RJ, et al. Among authors: gusterson b. Lancet. 1999 Sep 11;354(9182):896-900. doi: 10.1016/s0140-6736(98)11104-2. Lancet. 1999. PMID: 10489948 Clinical Trial.

10

Prenatal influences and breast cancer.

Anbazhagan R, Nathan B, Gusterson BA. Anbazhagan R, et al. Among authors: gusterson ba. Lancet. 1992 Dec 12;340(8833):1477-8. doi: 10.1016/0140-6736(92)92676-7. Lancet. 1992. PMID: 1360602 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters